Your browser doesn't support javascript.
loading
Clinical and phylogenetic influenza dynamics for the 2019-20 season in the global influenza hospital surveillance network (GIHSN) - Pilot study.
Quéromès, Grégory; Frobert, Emilie; Burtseva, Elena; Draganescu, Anca; Koul, Paravaiz A; Komissarov, Andrey; Laguna-Torres, V Alberto; Leblanc, Jason; López-Labrador, F-Xavier; Medic, Snezana; Mironenko, Alla; Otieno, Nancy A; Ruiz-Palacios, Guillermo M; Md, Tanriover; Josset, Laurence; Lina, Bruno.
Afiliación
  • Quéromès G; CIRI, Centre International de Recherche en Infectiologie, Team VirPatH, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Universit Claude Bernard Lyon 1, ENS de Lyon, Lyon F-69007, France.
  • Frobert E; CIRI, Centre International de Recherche en Infectiologie, Team VirPatH, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Universit Claude Bernard Lyon 1, ENS de Lyon, Lyon F-69007, France; Laboratoire de Virologie, Institut des Agents Infectieux (IAI), Hospices Civils de Lyon, 103 Grande Rue de la Croix-Rou
  • Burtseva E; Ministry of Health of the Russian Federation, FSBI "N.F. Gamaleya NRCEM", Moscow, Russian Federation.
  • Draganescu A; Matei Bals National Institute for Infectious Diseases, Bucharest, Romania.
  • Koul PA; Internal and Pulmonary Medicine, Sher-i-Kashmir Institute of Medical Sciences, Jammu and Kashmir, Srinagar, India.
  • Komissarov A; National Influenza Centre, Smorodintsev Research Institute of Influenza, Saint Petersburg, Russian Federation.
  • Laguna-Torres VA; Tropical Medicine Institute, San Marcos University and Clinica Internacional, Lima, Perú.
  • Leblanc J; Division of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health (NSH), Halifax, Nova Scotia, Canada.
  • López-Labrador FX; Virology Laboratory, Genomics and Health Area, FISABIO - Public Health, Generalitat Valenciana, Valencia, Spain; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.
  • Medic S; Department of Epidemiology, Faculty of Medicine, University of Novi Sad, Novi Sad 21000, Serbia; Center for Disease Control and Prevention, Institute of Public Health of Vojvodina, Novi Sad, Serbia.
  • Mironenko A; Department of Respiratory and other Viral Infections, L.V.Gromashevsky Institute of Epidemiology & Infectious Diseases NAMS of Ukraine, Kyiv, Ukraine.
  • Otieno NA; Kenya Medical Research Institute - Center for Global Health Research, Kisumu, Kenya.
  • Ruiz-Palacios GM; Department of Infectious Diseases, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico.
  • Md T; Hacettepe University Faculty of Medicine, Ankara, Turkey; Turkish Society of Internal Medicine, Ankara, Turkey.
  • Ngs Team-Lyon; CIRI, Centre International de Recherche en Infectiologie, Team VirPatH, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Universit Claude Bernard Lyon 1, ENS de Lyon, Lyon F-69007, France.
  • Gihsn Collaborators; CIRI, Centre International de Recherche en Infectiologie, Team VirPatH, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Universit Claude Bernard Lyon 1, ENS de Lyon, Lyon F-69007, France.
  • Josset L; CIRI, Centre International de Recherche en Infectiologie, Team VirPatH, Univ Lyon, Inserm, U1111, CNRS, UMR5308, Universit Claude Bernard Lyon 1, ENS de Lyon, Lyon F-69007, France; Laboratoire de Virologie, Institut des Agents Infectieux (IAI), Hospices Civils de Lyon, 103 Grande Rue de la Croix-Rou
  • Lina B; Laboratoire de Virologie, Institut des Agents Infectieux (IAI), Hospices Civils de Lyon, 103 Grande Rue de la Croix-Rousse, Lyon 69317 CEDEX 04, France; Centre National de Référence des virus des infections respiratoires dont la grippe, Lyon, France. Electronic address: bruno.lina@chu-lyon.fr.
J Clin Virol ; 152: 105184, 2022 07.
Article en En | MEDLINE | ID: mdl-35594785
ABSTRACT

BACKGROUND:

The Global Influenza Hospital Surveillance Network (GIHSN) has operated with the aim of investigating epidemiological and clinical factors related to severe influenza-related hospitalisations. STUDY

DESIGN:

A common GIHSN core protocol for prospective patient enrolment was implemented. Hospital personnel completed a standardized questionnaire regarding the included patients' medical history, compiled a hospitalisation summary, collected an upper respiratory swab sample for laboratory diagnosis, and genome sequencing was performed for a subset of samples. Patient data were compared according to influenza subtype, lineage, and phylogenetic groups using the Fisher's exact test.

RESULTS:

From September 2019 to May 2020, 8791 patients aged ≥5 years were included. Among them, 3021 (34.4%) had a laboratory-confirmed influenza diagnosis. Influenza A(H1N1)pdm09 dominated the season among all age groups, while the B/Victoria-like lineage accounted for over half of the infections among younger age groups (5-49 years). Sequencing of the hemagglutinin segment was possible for 623 samples and revealed an influenza A and B clade frequency among severe influenza hospitalisations similar to other medically attended surveillance networks, such as the WHO GISRS. No phylogenetic clustering was observed among hemagglutinin substitutions depending on the administration of supplemental oxygen or vaccine failure.

CONCLUSIONS:

The GIHSN confirms its ability as an international hospital-based active surveillance network to provide valuable information on influenza infection dynamics in hospital settings. Increasing the number of participating sites and compiling more complete data, such as genome sequencing, will allow the exploration of associations between viral factors, vaccine protection, and disease severity.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: J Clin Virol Asunto de la revista: VIROLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: J Clin Virol Asunto de la revista: VIROLOGIA Año: 2022 Tipo del documento: Article